Home
Live Updates
Prescription Digital Therapeutic for Schizophrenia Receives FDA Breakthrough Device Designation : comparemela.com
Prescription Digital Therapeutic for Schizophrenia Receives FDA Breakthrough Device Designation
The device is currently under clinical trial investigation as an adjunct treatment to standard of care therapy for experiential negative symptoms of schizophrenia.
Related Keywords
David Benshoof Klein ,
David Mohr ,
Society For Digital Mental Health ,
Us Food Drug Administration ,
Cains ,
Boehringer Ingelheim ,
Drug Administration ,
Breakthrough Device ,
Click Therapeutics ,
Digital Therapeutic ,
Assessment Interview ,
Negative Symptoms ,
Pleasure Scale ,
Negative Syndrome Scale ,
Social Performance Scale ,
Defeatist Beliefs Subscale ,
Dysfunctional Attitudes Scale ,
Patient Global Impression ,
Improvement Scale ,
Digital Mental Health ,
comparemela.com © 2020. All Rights Reserved.